November 20, 2020 – Trond Atle Smedsrud, EVP Strategic Investments, has on 19 November 2020 purchased 4 800 shares in Aker BioMarine AS at an average price of NOK 88,10 share through his wholly-owned investment company Hawi Holding AS. The shares were acquired on Merkur Market. Following the transaction, Smedsrud holds a total of 4 800 shares in Aker BioMarine AS.

For further information, please contact:
Katrine Klaveness, CFO
Phone: +47 991 58 915

About Aker BioMarine:
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, developing krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. The company is dedicated to improving human and planetary health.